FDA approves first COVID-19 vaccine
- Details
- Category: FDA

FDA approves new treatment for Pompe disease
- Details
- Category: FDA

Patients with Pompe disease have an enzyme deficiency that leads to the accumulation of a complex sugar, called glycogen, in skeletal and heart muscles, which cause muscle weakness and premature death from respiratory or heart failure.
FDA approves first interchangeable biosimilar insulin product for treatment of diabetes
- Details
- Category: FDA

FDA approves first oral blood thinning medication for children
- Details
- Category: FDA

FDA grants accelerated approval for Alzheimer's drug
- Details
- Category: FDA

FDA approves new drug treatment for chronic weight management, first since 2014
- Details
- Category: FDA

FDA authorizes additional monoclonal antibody for treatment of COVID-19
- Details
- Category: FDA

More Pharma News ...
- FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic
- FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review
- FDA revokes emergency use authorization for monoclonal antibody Bamlanivimab
- Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine
- AstraZeneca's COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
- Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
- EMA's safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events